Cargando…

Advances in the treatment of chronic myeloid leukemia

Although imatinib is firmly established as an effective therapy for newly diagnosed patients with chronic myeloid leukemia (CML), the field continues to advance on several fronts. In this minireview we cover recent results of second generation tyrosine kinase inhibitors in newly diagnosed patients,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eiring, Anna M, Khorashad, Jamshid S, Morley, Kimberly, Deininger, Michael W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182901/ https://www.ncbi.nlm.nih.gov/pubmed/21867560 http://dx.doi.org/10.1186/1741-7015-9-99

Ejemplares similares

Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
por: Ribeiro, Sara, et al.
Publicado: (2021)

Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia
por: Eiring, Anna M, et al.
Publicado: (2014)

RAPID CONVERSION OF CHRONIC MYELOID LEUKEMIA TO CHRONIC MYELOMONOCYTIC LEUKEMIA IN A PATIENT ON IMATINIB THERAPY
por: Khorashad, Jamshid S., et al.
Publicado: (2016)

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
por: Bolandi, Seyed Mohammadreza, et al.
Publicado: (2021)

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
por: Eiring, Anna M., et al.
Publicado: (2015)

A Coiled-Coil Mimetic Intercepts BCR-ABL1 Dimerization in Native and Kinase-Mutant Chronic Myeloid Leukemia
por: Woessner, David W., et al.
Publicado: (2015)

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
por: Stuckey, Ruth, et al.
Publicado: (2020)

Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemia
por: Eiring, Anna M., et al.
Publicado: (2014)

New concepts for CML clonality
por: Khorashad, Jamshid S., et al.
Publicado: (2013)

Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies
por: Zhou, Jianbiao, et al.
Publicado: (2018)

A role for FOXO1 in BCR–ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia
por: Wagle, M, et al.
Publicado: (2016)

Ongoing Clonal Evolution in Chronic Myelomonocytic Leukemia on Hypomethylating Agents: A Computational Perspective
por: Than, Hein, et al.
Publicado: (2018)

Advances in acute and chronic pancreatitis
por: Strum, Williamson B, et al.
Publicado: (2023)

GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn’s disease
por: Däbritz, Jan
Publicado: (2015)

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia
por: Claudiani, Simone, et al.
Publicado: (2019)

Population modeling of bosutinib exposure‐response in patients with newly diagnosed chronic phase chronic myeloid leukemia
por: Garrett, May, et al.
Publicado: (2023)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
por: Bencomo-Alvarez, Alfonso E., et al.
Publicado: (2021)

MicroRNAs: new players in acute myeloid leukaemia
por: Havelange, V, et al.
Publicado: (2009)

Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new
por: Frezza, Anna Maria, et al.
Publicado: (2017)

Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)

Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review
por: Cortes, Jorge E., et al.
Publicado: (2018)

Elastography-based screening for esophageal varices in patients with advanced chronic liver disease
por: Paternostro, Rafael, et al.
Publicado: (2019)

Advances in medical treatment for pancreatic neuroendocrine neoplasms
por: Li, Yuan-Liang, et al.
Publicado: (2022)

Adult eosinophilic esophagitis and advances in its treatment
por: Grando, Martina, et al.
Publicado: (2023)

Recent advances in the treatment of opioid use disorders–focus on long-acting buprenorphine formulations
por: Soyka, Michael, et al.
Publicado: (2021)

Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment
por: Diamantidis, Michael D, et al.
Publicado: (2021)

Recent Advances in Germanium‐Based Photoinitiator Chemistry
por: Haas, Michael, et al.
Publicado: (2018)

Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease
por: Procopet, Bogdan, et al.
Publicado: (2018)

Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016)

Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?
por: Rajappa, Senthil, et al.
Publicado: (2022)

Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Høiby, Niels
Publicado: (2011)

Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance
por: Gallo, Camilla, et al.
Publicado: (2022)

Diagnosis and treatment of chronic osteomyelitis based on nanomaterials
por: Zeng, Ming, et al.
Publicado: (2023)

Current status of non-surgical treatment of locally advanced pancreatic cancer
por: Spiliopoulos, Stavros, et al.
Publicado: (2021)

Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
por: Que, Qing-Yang, et al.
Publicado: (2022)

Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
por: Wu, Ya-Li, et al.
Publicado: (2019)

Advances in Alzheimer’s Disease Drug Development
por: Rafii, Michael S, et al.
Publicado: (2015)

Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach
por: Adamopoulou, Konstantina, et al.
Publicado: (2021)

Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer
por: Ye, Hui-Nan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ug6iaeuntq1g9dngpee0fntjvs